Ravi Pharmaceuticals

Vadodara, India Founded: 2015 • Age: 11 yrs
Manufactures and supplies a range of pharmaceutical products, including oral suspensions and formulations.

About Ravi Pharmaceuticals

Ravi Pharmaceuticals is a Healthcare company based in Vadodara (India) founded in 2015. It manufactures and supplies a range of pharmaceutical products, including oral suspensions and formulations. It operates on a B2B model. The company has 74 employees. Its Indian entity Ravi Pharmaceuticals Pvt Ltd reported revenue of β‚Ή21.23 Cr. Its focus areas include Pharmaceuticals, Manufacturing and Drug Formulation. Similar companies include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed similar companies have raised funding.

Company details

Ravi Pharmaceuticals manufactures and supplies a range of pharmaceutical products, including oral suspensions and formulations, focusing on providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and drug formulation. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.

  • Headquarters Vadodara, India
  • Employees 74
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website ravipharma.net
  • Legal Name Ravi Pharmaceuticals Pvt Ltd
  • Date of Incorporation 26 Sep, 1980
  • Jurisdiction Khambhat, Gujarat, India
Key Metrics
  • Annual Revenue
    ₹21.23 Cr

    FY 2024 · +15% YoY

  • Net Profit
    ₹35.7 Lakh

    FY 2024 · 2% margin

  • EBITDA
    ₹1.20 Cr

    FY 2024 · 6% margin

  • Employee Count
    74

Board of directors of Ravi Pharmaceuticals Pvt Ltd (Ravi Pharmaceuticals)

Ravi Pharmaceuticals Pvt Ltd is the primary company behind Ravi Pharmaceuticals. The board of Ravi Pharmaceuticals Pvt Ltd currently have 4 directors; the longest-serving is Naynaben Vikrambhai Patel, appointed in 1995. 2 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Naynaben Vikrambhai Patel
DIN 02552411
Director03 Feb 199531 yrs 9 moRavi Pharmaceuticals Pvt Ltd
Piyush Hathibhai Patel
DIN 01775386
Director03 Feb 199531 yrs 9 moRavi Pharmaceuticals Pvt Ltd
Vikrambhai Ambalal Patel
DIN 06556743
Director23 Apr 201511 yrs 6 moRavi Pharmaceuticals Pvt Ltd
Kamlesh Bhailalbhai Patel
DIN 07129388
Director23 Apr 201511 yrs 6 moRavi Pharmaceuticals Pvt Ltd

Financials of Ravi Pharmaceuticals

Figures of Ravi Pharmaceuticals Pvt Ltd, the primary company behind Ravi Pharmaceuticals, for FY 2024. Revenue was ₹21.23 Cr (+15% year on year). Net profit was ₹35.7 Lakh (2% margin). EBITDA was ₹1.20 Cr (6% margin). Revenue has grown at a compounded annual rate of +4% over three years and +7% over five years.

  • ₹21.23 CrRevenue · FY 2024 · +15% YoY
  • ₹35.7 LakhNet profit · 2% margin
  • ₹1.20 CrEBITDA · 6% margin
  • ₹10 LakhPaid-up capital
  • 74Employees (provident fund records)
  • +4%Revenue CAGR, 3 years
  • +7%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Ravi Pharmaceuticals Pvt Ltd are on its company page.

Premium access

Detailed financial statements for Ravi Pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Ravi Pharmaceuticals

Ravi Pharmaceuticals has 3 listed similar companies in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
akums.in2004Delhi, India$70M395
CDMO focusing on spectrum of dosage forms and therapeutic segments
jubl.com1978Noida, India
Company offering a suite of R&D and manufacturing services for small molecules and generics
neclife.com1995Chandigarh, India$46.85M175
Cephalosporin APIs and generic formulations are manufactured.
Premium access

Detailed similar companies of Ravi Pharmaceuticals

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Ravi Pharmaceuticals

Ravi Pharmaceuticals was founded in 2015.

Ravi Pharmaceuticals is headquartered in Vadodara, India. It is registered at Vadodara, Gujarat, India.

Ravi Pharmaceuticals has 74 employees.

The primary company behind Ravi Pharmaceuticals, Ravi Pharmaceuticals Pvt Ltd, reported revenue of β‚Ή21.23 Cr for FY 2024, up 15% year on year.

Ravi Pharmaceuticals manufactures and supplies a range of pharmaceutical products, including oral suspensions and formulations, focusing on providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and drug formulation. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.

Ravi Pharmaceuticals's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.

Ravi Pharmaceuticals operates through Ravi Pharmaceuticals Pvt Ltd.

The legal entities of Ravi Pharmaceuticals currently have 4 directors, including Naynaben Vikrambhai Patel, Vikrambhai Ambalal Patel, Kamlesh Bhailalbhai Patel and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available